Bryce Rhodehouse, DO
Internal Medicine · Temple, TXNPI 1659809630
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Abbott accounts for 63.1% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $1,326, more than ten times the $11 reported in 2020.
Across 64 payments — averaging $38.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$376
- AstraZeneca$92
- Lantheus Medical Imaging, Inc.$73
- Novartis$72
- Amgen$69
- plus $231 from 10 others
What the payments were for
- Travel & lodging$1,06543%
- Food & beverage$1,10445%
- Education$30712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $1,564 |
| Medtronic | 24 | $376 |
| AstraZeneca | 2 | $92 |
| Lantheus Medical Imaging, Inc. | 1 | $73 |
| Novartis | 4 | $72 |
| Amgen | 5 | $69 |
| Pfizer | 3 | $49 |
| Boston Scientific | 2 | $34 |
| GE HealthCare | 1 | $30 |
| Heartflow, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| Abiomed | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$986
- ENSITE PRECISION$227
How this compares
$2,477 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 134 | $132,409 |
| FarxigaDapagliflozin Propanediol | 103 | $85,182 |
| BrilintaTicagrelor | 41 | $38,867 |
| OzempicSemaglutide | 25 | $24,847 |
| EntrestoSacubitril/Valsartan | 17 | $20,220 |
| XareltoRivaroxaban | 18 | $12,826 |
| Repatha SureclickEvolocumab | 11 | $8,847 |
| Atorvastatin Calcium | 194 | $2,143 |
| Metoprolol Succinate | 148 | $1,570 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 26 | $1,238 |
| Ezetimibe | 50 | $1,128 |
| Torsemide | 26 | $974 |
| Flecainide Acetate | 21 | $869 |
| Amiodarone Hcl | 33 | $800 |
| SotalolSotalol Hcl | 19 | $628 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $49 | $132,409134 claims |
| AstraZenecaFarxiga, Brilinta | $92 | $124,049144 claims |
| NovartisEntresto | $72 | $20,22017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Temple
- Hameed AliTemple$773K
- Catherine McNealTemple$187K
- Timothy MillerTemple$146K
- Michael VolkTemple$65K
- Spencer BerthelsenSugar Land$891K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.